Latest filing published 11 Jan 2007 for La Jolla Pharmaceutical Co, €344.
Insider track record
No signal scores available.
Paul Jenn: trading record in brief
Paul Jenn discloses dealings in La Jolla Pharmaceutical Co to SEC (Form 4). Over a trading history stretching from 31 March 2006 to 10 January 2007, the count stands at 8 filings.
No open-market purchase appears, only 2 sales worth €28k. So far in 2007, the count stands at no purchases and 2 sales.
The newest entry dates from 11 January 2007: a transaction of €344, in La Jolla Pharmaceutical Co. Typically, a trade is published a median of 15 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Jenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 176 shares@ US$2.58Common StockSEC:0001209191-07-003381:0
- 6,630 shares@ US$3.09Common StockSEC:0001209191-07-003381:1
- 5,000 shares@ US$3.11Common StockSEC:0001209191-07-000320:0
- 148 shares@ US$3.06Common StockSEC:0001209191-06-065618:0
- 1,819 shares0Common StockSEC:0001209191-06-065618:1
- 174 shares@ US$3.06Common StockSEC:0001209191-06-065618:2
- 1,500 shares@ US$3.12Common StockSEC:0001209191-06-065618:3
- 174 shares@ US$3.06Common StockSEC:0001209191-06-024471:0
8 of 8 declarations
